Premium
Transition‐Metal Complexes Based on a Sulfonate‐Containing N‐Donor Ligand and Their Use as HIV Antiviral Agents
Author(s) -
GarcíaGallego Sandra,
Serramía M. Jesús,
Arnaiz Eduardo,
Díaz Laura,
MuñozFernández M. Angeles,
GómezSal Pilar,
Ottaviani M. Francesca,
Gómez Rafael,
de la Mata F. Javier
Publication year - 2011
Publication title -
european journal of inorganic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.667
H-Index - 136
eISSN - 1099-0682
pISSN - 1434-1948
DOI - 10.1002/ejic.201001121
Subject(s) - chemistry , sulfonate , ligand (biochemistry) , human immunodeficiency virus (hiv) , transition metal , medicinal chemistry , metal , salt (chemistry) , stereochemistry , sodium , receptor , organic chemistry , virology , biochemistry , catalysis , biology
Herein, we describe the synthesis and characterization of a sulfonate‐containing N‐donor ligand in its sodium salt and acid forms, Na 2 [(DES)MeN(CH 2 ) 2 NMe(DES)] · 2H 2 O ( 1 ) and [(DES)MeN + H(CH 2 ) 2 N + HMe(DES)] · H 2 O ( 2 ), and its corresponding metal complexes, [{(DES)MeN(CH 2 ) 2 NMe(DES)}M(H 2 O) 2 ] · n H 2 O [M = Ni ( 3 ), Co ( 4 ), Cu ( 5 ) and Zn ( 6 )]. Treatment of HIV‐infected MT‐2 cells with Ni, Co and Cu complexes inhibit virus replication up to 50–70 % both in pre‐ and post‐infected cells as a result of dual preventive and therapeutic behaviour.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom